APG Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,726
| Closed | -$1.13M | – | 538 |
|
|
2025
Q4 | $1.13M | Buy |
2,726
+688
| +34% | +$320K | ﹤0.01% | 524 |
|
|
2025
Q3 | $727K | Buy |
2,038
+235
| +13% | +$79K | ﹤0.01% | 518 |
|
|
2025
Q2 | $441K | Buy |
1,803
+88
| +5% | +$26.3K | ﹤0.01% | 529 |
|
|
2025
Q1 | $489K | Sell |
1,715
-830
| -33% | -$284K | ﹤0.01% | 531 |
|
|
2024
Q4 | $867K | Sell |
2,545
-627
| -20% | -$230K | ﹤0.01% | 522 |
|
|
2024
Q3 | $1.02M | Sell |
3,172
-97,466
| -97% | -$32.9M | 0.01% | 364 |
|
|
2024
Q2 | $29.9M | Sell |
100,638
-17,604
| -15% | -$4.66M | 0.05% | 284 |
|
|
2024
Q1 | $25.2M | Buy |
118,242
+16,880
| +17% | +$3.81M | 0.04% | 311 |
|
|
2023
Q4 | $20.2M | Buy |
101,362
+5,716
| +6% | +$1.32M | 0.04% | 325 |
|
|
2023
Q3 | $21.6M | Sell |
95,646
-2,685
| -3% | -$618K | 0.04% | 317 |
|
|
2023
Q2 | $19.9M | Buy |
98,331
+59,526
| +153% | +$13.2M | 0.04% | 342 |
|
|
2023
Q1 | $8M | Buy |
+38,805
| New | +$9.57M | 0.02% | 445 |
|
|
2021
Q3 | – | Sell |
-6,500
| Closed | -$983K | – | 947 |
|
|
2021
Q2 | $983K | Sell |
6,500
-8,100
| -55% | -$1.54M | ﹤0.01% | 785 |
|
|
2021
Q1 | $2.08M | Buy |
+14,600
| New | +$2.43M | ﹤0.01% | 708 |
|
|
2020
Q3 | – | Sell |
-24,409
| Closed | -$2.63M | – | 1056 |
|
|
2020
Q2 | $2.63M | Buy |
+24,409
| New | +$2.75M | ﹤0.01% | 746 |
|
|
2019
Q4 | – | Sell |
-10,197
| Closed | -$746K | – | 973 |
|
|
2019
Q3 | $746K | Sell |
10,197
-51,803
| -84% | -$4.17M | ﹤0.01% | 871 |
|
|
2019
Q2 | $4.25M | Sell |
62,000
-709,600
| -92% | -$66.4M | 0.01% | 656 |
|
|
2019
Q1 | $80.7M | Buy |
771,600
+87,200
| +13% | +$10.2M | 0.15% | 183 |
|
|
2018
Q4 | $65.2M | Buy |
684,400
+12,200
| +2% | +$1.41M | 0.13% | 196 |
|
|
2018
Q3 | $74M | Buy |
672,200
+1,200
| +0.2% | +$148K | 0.13% | 201 |
|
|
2018
Q2 | $65M | Sell |
671,000
-7,400
| -1% | -$813K | 0.12% | 216 |
|
|
2018
Q1 | $62M | Sell |
678,400
-27,500
| -4% | -$3.49M | 0.12% | 220 |
|
|
2017
Q4 | $87M | Buy |
705,900
+53,900
| +8% | +$6.85M | 0.16% | 188 |
|
|
2017
Q3 | $76.4M | Buy |
652,000
+128,404
| +25% | +$16.4M | 0.13% | 220 |
|
|
2017
Q2 | $67.9M | Sell |
523,596
-18,535
| -3% | -$2.31M | 0.12% | 245 |
|
|
2017
Q1 | $73.4M | Buy |
542,131
+56,639
| +12% | +$8.58M | 0.13% | 233 |
|
|
2016
Q4 | $66M | Buy |
485,492
+68,600
| +16% | +$8.76M | 0.12% | 238 |
|
|
2016
Q3 | $49.2M | Buy |
416,892
+176,900
| +74% | +$21.3M | 0.09% | 292 |
|
|
2016
Q2 | $25.4M | Buy |
239,992
+54,500
| +29% | +$6.08M | 0.05% | 375 |
|
|
2016
Q1 | $20.7M | Buy |
185,492
+170,120
| +1,107% | +$21.5M | 0.04% | 392 |
|
|
2015
Q4 | $2.41M | Hold |
15,372
| – | – | 0.01% | 670 |
|
|
2015
Q3 | $2.02M | Hold |
15,372
| – | – | ﹤0.01% | 684 |
|
|
2015
Q2 | $2.67M | Buy |
+15,372
| New | +$2.77M | 0.01% | 697 |
|
|
2015
Q1 | – | Sell |
-2,100
| Closed | -$272K | – | 760 |
|
|
2014
Q4 | $272K | Buy |
+2,100
| New | +$271K | ﹤0.01% | 765 |
|
Other funds holding UTHR
ACA
VPM
VCM
APG Asset Management's UTHR Position: Q1 2026 in Review
APG Asset Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 2,726 shares — an estimated $1.13M sold.
APG Asset Management first reported a position in UTHR in Q4 2014 and held it in 34 quarters. The position peaked at $87M in Q4 2017. 853 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- APG Asset Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- APG Asset Management sold 2,726 United Therapeutics shares in Q1 2026, an estimated $1.13M.
- APG Asset Management first reported a position in United Therapeutics in Q4 2014 and held it in 34 quarters.
- APG Asset Management's United Therapeutics position peaked at $87M in Q4 2017.
- 853 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.